Nicholas Investment Partners, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$83.14 - $145.99 $3.24 Million - $5.69 Million	-38,977 Reduced 22.11%	137,306 $20 Million
Q1 2022 May 10, 2022	SELL	$110.08 - $142.92 $5.57 Million - $7.23 Million	-50,588 Reduced 22.3%	176,283 $20.9 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $2.49 Million - $3.71 Million	24,966 Added 12.37%	226,871 $31.3 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $16 Million - $22.5 Million	-161,803 Reduced 44.49%	201,905 $28 Million
Q2 2021 Aug 10, 2021	SELL	$65.78 - $105.02 $785,807 - $1.25 Million	-11,946 Reduced 3.18%	363,708 $35.3 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $6.75 Million - $9.66 Million	105,292 Added 38.94%	375,654 $25.7 Million
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $1.2 Million - $1.81 Million	18,416 Added 7.31%	270,362 $23.2 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $11.4 Million - $15 Million	192,988 Added 327.33%	251,946 $16.4 Million
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $2.95 Million - $7.54 Million	-101,553 Reduced 63.27%	58,958 $4.31 Million
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $462,002 - $962,128	16,794 Added 11.69%	160,511 $5.46 Million
Q4 2019 Feb 13, 2020	SELL	$40.86 - $57.65 $825,453 - $1.16 Million	-20,202 Reduced 12.32%	143,717 $7.82 Million
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $50,874 - $67,328	1,361 Added 0.84%	163,919 $6.84 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $2.17 Million - $3.65 Million	54,516 Added 50.46%	162,558 $7.12 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $152,992 - $236,181	4,432 Added 4.28%	108,042 $5.56 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $493,731 - $711,968	16,596 Added 19.07%	103,610 $3.83 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $17,444 - $22,876	-532 Reduced 0.61%	87,014 $3.27 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $16,368 - $29,306	-693 Reduced 0.79%	87,546 $3.46 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $1.98 Million - $3.05 Million	88,239 New	88,239 $2.27 Million
Q4 2017 Feb 14, 2018	SELL	$20.44 - $35.56 $1.97 Million - $3.43 Million	-96,367 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $2.27 Million - $3.68 Million	96,367	96,367 $3.6 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account